SEC Form 4 · accession 0001171843-19-001650
Zomedica Corp. · ZOMDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald Solensky Jr.
Officer — President and CEO · Director · 10% Owner
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001684144
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Mar 8, 2019 | M | 164,473 | $1.52 | A | 38,315,409 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.52 | Mar 8, 2019 | M | 164,473 | D | Jan 10, 2019 | Jan 10, 2021 | Common Shares, without par value | 164,473 | 1,935,527 | D |